Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial, Part I: Quality Control, Comparisons, and Variability [Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology]

Conclusions.
Spectral-domain OCT provides reliable continuous variables and quantified assessment of structural alterations due to papilledema. (ClinicalTrials.gov number, NCT01003639.)

Source: Investigative Ophthalmology - December 12, 2014 Category: Opthalmology Authors: OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study Group Tags: Eye Movements, Strabismus, Amblyopia, and Neuro-Ophthalmology Source Type: research